Propofol (2,6-diisopropylphenol) is widely used in total intravenous anesthesia. An unknown drug concentration in blood always leads to some side effects in patients with propofol injection. However, the drug concentration in the blood is hard to be continuously measured since invasive sampling causes a loss of blood at each measurement. Here, we introduced a virtual surface acoustic wave sensor array (VSAWSA) to non-invasively detect the propofol concentration in blood through exhaled gases. Calibration was conducted by a parallel test using gas chromatography and mass spectrometry (GC-MS) with solid-phase micro-extraction (SPME) for preconcentration. The limit of detection of VSAWSA reached 0.15 nmol/L for propofol. Six cases of clinical trials was conducted to compare the exhaled propofol concentrations to the plasma concentrations controlled by target-controlled infusion (TCI). The calibration by GC-MS ensured the feasibility, reliability, and accuracy of the VSAWSA (R = 0.9904, p <0.001). The clinical monitoring data by VSAWSA showed an excellent consistency with TCI.
Introduction
Propofol (2,6-diisopropylphenol) is a common anesthetic drug that is widely used in clinical practices since it allows rapid awakening and reduces the incidence of postoperative nausea and vomiting. 1 Low-dosage awareness and hemodynamic instability can still be found in patients with propofol injection. Therefore, the continuous measurement of propofol is significantly helpful for controlling the anesthesia during surgeries. The concentration of propofol in plasma is a reliable reference. However, there is no efficient method to continuously monitor the plasma concentration without other side-effects. 2 Target-controlled infusion (TCI), 3, 4 as a widely employed method in clinical, is based on an established pharmacokinetic and pharmacodynamics model. Once the target propofol concentration in the blood is set, the required dose of propofol to achieve and maintain the target concentration will be calculated and infused to patients. Although TCI is quite accurate in predicting propofol concentration in blood for a restricted population, 5 it cannot provide the same performance for a special group of patients, such as patients undergoing liver transplantation.
The measurement of propofol in the patient's expiratory air can be used as a reference for propofol plasma levels, this idea has been tried by using proton transfer reaction mass spectrometer (PTR-MS) 6, 7 and ion-molecule reaction mass spectrometry (IMR-MS). 8 However, IMR-MS are not suitable to be equipped in an operation room to monitor exhaled propofol because of the volume and noise of its vacuum system. PTR-MS with an optical detection system 9,10 is a portable device. However, this method is mainly based for the reaction of H3O + ions, which is sensitive to most kinds of the volatile organic compounds (VOCs) in the breath. Some of these VOCs will interfere with the detection of propofol. Thus, PTR-MS had a limited power to detect propofol in a complex gas background.
Meanwhile, surface acoustic wave (SAW) sensors have been widely implemented in the breath-sensing field owing to its high-sensitivity, low-cost and small size. However, the SAW sensor itself is not selective to different compounds in the breath. Thus, some functional membranes were modified on the surface of the sensor. Zhang et al. 11 used a SAW immunosensor to detect carcinoembryonic antigen in exhaled breath condensates. Furthermore, Matatagui et al. 12 deposited different nanofibers on the SAW sensors to fabricate a sensing array, which could characterize different VOCs. Melker et al. 13 also claims that a SAW sensor array fabricated with functional membranes was an excellent selection for the detection of anesthetics. However, these physical sensor arrays required the integration of multiple sensors, while the complexity of signal detection and processing was increased.
Here, we introduce a non-invasive method to measure the concentration of propofol in the breath by using SAW sensors combined with a capillary column 14, 15 as a virtual surface acoustic wave sensor array (VSAWSA). This technique can be used to non-invasively monitor the propofol concentration of a patient during surgery. Based on the correlation between the blood propofol concentration and the expiratory concentration, 16, 17 the VSAWSA can be used as a reference to monitor anesthesia.
In this paper, we verified the proposed technique in applications of the propofol measurement by calibrating the VSAWSA using gas chromatography and mass spectrometry with a solid-phase micro-extraction for preconcentration (SPME-GC-MS). We used VSAWSA to on-line monitor the propofol concentrations in expiratory air, and compared it with the concentrations from TCI. The results proved that VSAWSA is a convenient way to monitor the exhaled propofol concentration, which is quite consistent with TCI. This provides a promising reference for non-invasively monitoring of the blood concentration in patients who are not predicable by pharmacokinetic and pharma codynamics models.
Method

System design of the VSAWSA
The system design of VSAWSA is shown in Fig. 1 . The whole system employed a 3-m long DB-5 capillary column (180 μm i.d.; film thickness 0.1 μm), in which helium was used as a carrier gas. A 10-mg Tenax TA, which can reduce the detection limit 1 -2 magnitude, was used as an absorptiondesorption medium. An embedded micro controller unit (MCU) was used to control the temperature of SAW sensors, the heating process of the capillary column and the flow rate of the carrier gas, as well as to operate the position of a 6-way valve injector. In the first 6-way valve's state, the sample gas flowed into the pneumatic apparatus with the suction of the pump, and was absorbed in the Tenax TA sorbent tube. Then, the valve turned to the second state and the sorbent tube was ultra-fast heated to 250 C to let the absorbed gas desorb and flow into the capillary column simultaneously. Finally, the separated gas components' quantities would be measured by SAW. The whole process in one circle of analysis was done in 10 seconds. Furthermore, the size of the system was small enough to be portable.
In addition, different from traditional gas chromatography, our VSAWSA employed a resistive-heating of capillary column. This makes a far more efficient programmed heating than an oven, and reduces the volume of the device. 18 The whole process of detection can be done in 90 s, and the instrument has a portable size to be equipped in the operation room.
Design of the surface acoustic wave sensor
For the SAW detector, two sensors were deployed simultaneously. One was a reference sensor and the other was a working sensor. They were 36 Y-X Quartz based SAW sensors with an approximately 500 MHz central frequency. Additional parameters are listed in Table 1 . Figure 2A is a picture of the SAW detector. Moreover, the real central frequencies are demonstrated in Fig. 2B .
According to the above parameters, we can calculate the sensor sensitivity for mass deposition by using the SAW sensors mass sedimentary effect formula: 
Here, f0 is the sensor central frequency. h and ρ are the thickness and density of the sensitive membrane. k1/k2/k3 are the substrate Fig. 1 System design of the virtual surface acoustic wave sensor array. material constants. Thus, the SAW sensor has a good theoretical sensitivity. When substances are deposited on the sensitive area of the working sensor, the central frequency changes. By measuring the change of the difference of the frequency of the two sensors, the mass of the deposited substances was determined. Besides, a Peltier module was employed for the temperature control of the SAW sensor. The temperature feedback was monitored by a Heraeus ® PT100 sensor, whose measurement error is within plus or minus 0.1 C.
Calibrating VSAWSA by GC-MS
VSAWSA has the advantage of being portable and allows an on-line detection. To make sure whether its detection is sufficiently reliable and feasible for clinical utilization, GC-MS was employed as a standard to calibrate the instrument.
Preparation of standard gas samples
Concentrations of 0.4, 0.5, 1.0, 2.0, 4.0 nmol/L propofol from the same stock solution of propofol in methanol were prepared. The mixed gas was produced by gas generator (MF-3B, developed by China National Metrology Technology Development Co.) and was kept in a 2-L Tedlar bag.
Preconcentration
Solid-phase micro-extraction (SPME) with 100 μm polydimethylsiloxane (PDMS) coating fibers (57300-U, Supleco, USA) was applied for preconcentration. Before the preconcentration, the SPME fiber was preconditioned at 260 C for 12 min. Then, SPME fiber pierced the septum of a Tedlar bag and was kept at 40 C in an oven for 10 min.
GC-MS analysis
This step was performed by a SHIMADZU GCMS-QP2010 plus with a 30-m, o.d. 0.25 mm, i.d. 0.25 μm RESTEK ® RTX-5 column. The preconcentrated SPME fiber was thrust into the GC injection port, of which the temperature was at 260 C. The injection time was 1 min. The GC temperature program started at 120 C for 12 min was then raised at a rate of 15 C/min, and finally held for 2 min at 300 C. The MS ion source temperature was set at 250 C with a mass range from 35 -250 amu. 20 
VSAWSA analysis and evaluation
Firstly, turn on the VSAWSA system without any sample gas input to eliminate any interferences of the baseline. A syringe installed at the inlet of VSAWSA was thrust through the septum of Tedlar bag to inhale the mixed sample gas in the process of pumping. The temperature of SAW sensor, capillary column, 6-way valve and inlet were set at 30, 40, 165, and 200 C, respectively. The heating rate was 10 C/s and the column flow was 3.0 sccm. 21 Every time after the detection was complete, the surface of the sensor would be heated to 120 C for 15 s, to make the central frequency of the sensor return to the original baseline.
The limit of detection (LOD) was evaluated using the average value of the signal noise. The LOD of the SAW sensor is 3-times the average signal noise. The linear detection range was evaluated using standard gas samples with the concentration from 0.4 to 4.0 nmol/L, since this range covered the concentrations of propofol in exhaled gases of patients during surgery. 6, 7 To further explore the detection ability of VSAWSA, we used the original medicine with a propofol concentration of 10 mg/mL to test whether the sensor would saturate or not.
Comparing on-line VSAWSA detection of propofol with targetcontrolled infusion
Our research group cooperated with the second affiliate hospital of Zhejiang University School of Medicine, Hangzhou, China in the clinical study of propofol detection in expiratory air. We had the clinical study approval from Office of Human Research Protection (OHRP) at Zhejiang University with the institutional review board (IRB-SAHZU-2013 NO.14). Written informed consents were obtained from 6 patients.
The expiratory air was sampled during surgery when the patient was in the state of anesthesia. The gas inlet of VSAWSA was a T piece, a heated stainless steel tube with a length of 0.5 m, an outer diameter of 2.5 mm and an inner diameter 1.5 mm. It was connected to the expiratory tube to collect expiratory air from the extra breath circle of the patient. There was an electric and heat isolation layer covered on a tube to avoid possible electric or burn injuries.
The results of VSAWSA detection were compared with that of target-controlled infusion (TCI). The TCI instrument that we used in the hospital was a GRASEBY anesthesia pump 3500. TCI is based on pharmacokinetic and pharmacodynamics mathematical models. The propofol concentration in blood can be read out in real time, and a control value can be set using a GRASEBY anesthesia pump 3500. It is an intravenous dose method to help control or maintain an adequate depth of anesthesia by adjusting the drug concentration, TCI is widely used in clinical anesthesia monitoring and proved to be effective. 3, 4 The targets of the propofol concentration was set according to the anesthesiologist's advice during the operation. Typically, the required propofol concentration for the maintenance of anesthesia was from 1 to 10 μg/ml. 16 After the infusion of propofol by TCI, continuous monitoring of propofol concentration in expiratory by VSAWSA began simultaneously. The propofol concentration in expiratory was measured every approximately 90 s. The whole process of the experiment lasted for 30 to 60 min when the change of the propofol concentration became smooth. A strategy of mixed anesthetics (sevoflurane and propofol) was used to maintain patients in the state of anesthesia.
This allows changing the target propofol concentration by TCI while keeping the patients under anesthesia during the duration of an experiment.
Results and Discussion
Calibrating VSAWSA by GC-MS
A chromatogram (Fig. 3) showed the headspace analysis of the original medicine with propofol concentration of 10 mg/mL was completed in seconds by our VSAWSA system. The results demonstrated that VSAWSA had a wide detection range and was capable of detecting propofol with a very high concentration. Figure 3D is a sample exhaled gas analysis of patient under total intravenous anesthesia. Propofol has an exogenous intake, and the body itself does not produce propofol. If there were compounds that have similar retention time with propofol existing in the breath, it would certainly influence the detection of propofol. However, propofol has a molecular weight of 178. It is relatively heavier than the endogenous molecules in exhaled gas. Thus, they could be divided by the capillary column of the VSAWSA. In Fig. 3D , we can easily see that the peak of propofol was detected in the breath. Compared to the conventional methods, VSAWSA has a unique selectivity for propofol in the gas-phase, along with a portable size.
Moreover, Fig. 4 shows the calibration curves of a standard propofol gas sample with GC-MS. Each concentration of standard propofol gas samples was analyzed by GC-MS three times and by VSAWSA five times. Figure 4A demonstrated the chromatogram of GC-MS, which confirmed the reliability of the gas samples and the GC-MS calibration method. Meanwhile, Fig. 4B shows the response of VSAWSA. The relative standard deviation (RSD) of five VSAWSA measurements of a same propofol concentration were all less than 5%, which showed a good reproductivity of VSAWSA. Figure 4C shows a strong correlation (R 2 = 0.9904, p <0.001) between the responses of VSAWSA and GC-MS. The results indicate that VSAWSA has a good linear characteristic and reproductivity for the quantitative detection of propofol in the gas phase and proves that VSAWSA is a reliable tool to quickly analyze propofol in exhalations.
The average noise of the SAW signal was under 40 Hz/s in the VSAWSA analysis, the height of the peak of propofol (0.4 nmol/L, the lowest concentration in the calibration experiment) was 319 Hz/s. Thus, according to the signal-tonoise ratio of 3 times, we can calculate the limit of detection (LOD) of propofol using formula (2):
Harrison and Hornuss have measured the exhaled propofol concentration of clinical patients by PTR-MS 7 and IMR-MS, 8 which are different from our research concerning the aspects of the research method and the application. Our results by VSAWSA have verified their results. Not like their analyses of some other propofol metabolites, we detected free propofol dissolved in blood. VSAWSA is small and sufficiently fast to be used for on-line monitoring due to its novel capillary column heating method. The system size has been reduced to 40 × 30 × 20 cm, which is portable to be used on many occasions, and would probably make the device an accessory of a breathing machine. The measurement time of VSAWSA is reduced to approximately 90 s, compared with an analysis time of 30 min by traditional gas chromatography. Without the system's on-line and on-site character, it is hard to clinically monitor the exhaled propofol concentration. Besides, its detection limit is adequate for clinical propofol monitoring.
Comparing on-line VSAWSA detection of propofol with targetcontrolled infusion
For good linear characteristic and reproductivity of VSAWSA, on-line detection of the propofol concentrations in expiratory by VSAWSA is both feasible and reliable. Totally, the exhaled propofol concentration samples of 6 patients who were anesthetized by target-controlled infusion (TCI) were on-line tested by VSAWSA. In addition, the results were compared with that of TCI.
No exhaled propofol was detected in the breath of the patients when no propofol was infused at the first beginning (Fig. 5 ). An increase in the exhaled propofol concentration was detected within 90 s (which is the detection interval of VSAWSA, as mentioned above) after the concentration of plasma propofol was targeted to a certain concentration by TCI. The concentration of exhaled propofol kept increasing while the target of the plasma propofol concentration increased from 1 to 4 μg/ml. The SAW responses decreased along with the target concentration decreased from 4 to 0 μg/ml. In addition, there was a delay of propofol concentrations change in the exhalation. Although the detection interval was 90 s, while compared to the whole monitoring cycle, the VSAWSA system can be used to on-line monitor the exhaled propofol concentration. In Fig. 5 , the TCI curves represent the target concentrations, which are different from the read-out concentration of TCI. For example, the target was set at 4.0 μg/ml but the read-out value by TCI was actually 3.8 μg/ml.
Another experiment was for those patients who used TCI to maintain the anesthesia by propofol. After the cessation of propofol infusion, the detection of VSAWSA and the read-out value of TCI were recorded simultaneously (Fig. 6) . The TCI control value was 0 μg/ml since the infusion stopped. The responses of VSAWSA and the read-out values of TCI declined consistently. Different from Fig. 5 , the TCI curves presented in Fig. 6 were the read-out values, which were more practical and accurate than the control values.
From the above experiments, VSAWSA had a calibration linearity of 0.9904, which was tested with standard gas samples by SPME-GC-MS. The good linearity proves that fast VSAWSA is both reliable and feasible for propofol detection. The clinical exhaled propofol monitoring by VSAWSA showed a strong correlation with the results of the plasma monitor by TCI.
This proves the reliability of VSAWSA in clinical propofol monitoring. Besides, VSAWSA could also provide point-ofcare monitoring. We conclude that VSAWSA is an on-line and on-site method for clinical exhaled propofol monitoring.
Comparing the exhaled propofol detection with a clinical applied TCI, the trends of the SAW responses of the exhaled concentration are quite consistent with the concentrations from TCI. However, the absolute value of SAW varies in different patients. For example, the max SAW response to 4 μg/ml TCI was around 400 Hz in one patient, while that in another patient was around 600 Hz. This difference is related to the patient's conditions, like age, weight, liver function, etc. To eliminate the influences of different patient characteristics, the experimental subjects will be grouped by different situations, like age, weight or liver function. Thus, it will require much more patient samples taking and experiments, which will be our focus in the future. Besides, further studies of metabolic models can help to know the basic mechanism behind. In this study, TCI was employed as the standard clinical propofol monitor method. The limitation is that the value of TCI was derived from mathematical models. This means that it still has variations to the actual plasma propofol concentration. A calibration procedure using a blood samples during a surgery might be helpful to minimize these variations. Parallel simultaneous tests of not only exhaled propofol concentration, but also the directly measured plasma propofol concentration, is necessary. Finally, by comparing the blood results curve and the exhaled results curve, a more reliable relationship between the plasma propofol and exhaled propofol can be determined.
Conclusion
In a summary, we have provided a novel VSAWSA method to monitor the exhaled propofol concentrations. This method shows a great linearity in calibration and a strong correlation with the clinical standard, which allows for its continuous and noninvasive monitoring of exhaled propofol in clinical situations.
